The short answer
Falling estrogen levels during the menopausal transition can contribute to thinner, drier vaginal tissues and symptoms such as irritation, burning, discomfort during sex, and urinary complaints. These changes are often discussed as part of genitourinary syndrome of menopause, or GSM. Menopausal status is useful context, but it is not a diagnosis: infection, contact irritation, vulvar skin disease, urinary problems, and other conditions can cause or coexist with similar symptoms. 1 2 3 11
The most useful first distinction is where the symptom is located. Itching or visible change on the external vulvar skin is not the same problem as discomfort that feels primarily inside the vagina. Bleeding after menopause, a persistent sore or lump, marked skin change, fever with urinary symptoms, or rapidly worsening illness should not be managed with an indefinite dryness-product trial. 4 5 6 7 10
Start by locating where the itching is
The vulva is the external genital area around the vaginal opening. It includes skin that can be affected by friction, detergents, fragranced products, inflammatory skin conditions, and local injury. Symptoms described as “vaginal itching” may actually be on the vulva, inside the vagina, or in both places. 4 11
External symptoms may include itch, burning, soreness, fragile skin, color or texture changes, cracks, white patches, or a focal sore. Internal vaginal symptoms may be described as dryness, burning, discomfort with penetration, or a change in discharge. Urinary burning, urgency, or frequency adds another concern that may need assessment. Knowing where you feel the symptom helps a clinician decide what to examine, but location alone still does not determine the cause.
When menopause-related tissue change is plausible
Lower estrogen can contribute to thinner and drier vaginal tissues. GSM can include genital and urinary symptoms during and after the menopausal transition. Current multidisciplinary guidance emphasizes that diagnosis requires considering other or coexisting causes rather than assuming that age and dryness explain the presentation. 1 2
A dryness pattern may include reduced lubrication, irritation, burning, or pain with sexual activity. Urinary urgency, frequency, or discomfort may occur in the same life stage. Those features can fit GSM, but they can also overlap infection, irritation, pelvic-floor problems, urinary disease, or vulvar skin conditions. A website cannot make that distinction from a symptom list. 1 3 10 11
While lower estrogen during menopause often causes dryness and itching, keep an open mind, as skin conditions and infections can also occur.
Irritation and contact exposure remain possible
Scented washes, wipes, sprays, detergents, fabric products, repeated washing, heat, moisture, and rubbing can aggravate vulvar skin. A product does not have to be new to be relevant; sensitivity can develop after a period of previous tolerance. Improvement after stopping an exposure may strengthen the history, but it does not identify an allergen or prove that no other condition is present. 2 4
While symptoms are being sorted out, avoid douching and avoid putting ordinary body creams or lotions inside the vagina. External skin care and intravaginal product use are different routes. A product intended for one location should not be moved to another simply because the label uses broad “intimate care” language. 3 11
Persistent or worsening symptoms should not trigger a cycle of adding more fragranced or active products. Repeated product switching can obscure the pattern and may add irritation.
Use symptoms and testing to tell vaginal causes apart
Vulvovaginal candidiasis can cause itching, soreness, external urinary burning, and discharge, but those symptoms are not specific to yeast. Finding Candida without relevant signs or symptoms also does not automatically establish a condition that needs treatment. 8
A previous yeast diagnosis does not prove that a new episode is the same. CDC guidance recommends evaluation and testing when symptoms persist after an over-the-counter yeast treatment or recur within less than two months. That interval is not a rule to wait when there is pain, bleeding, a sore, pregnancy, fever, or another warning sign. 8
Bacterial vaginosis, trichomoniasis, other infections, irritation, and hormonal changes can overlap. Vaginal pH may contribute information, but pH alone does not diagnose bacterial vaginosis or identify the cause of itching. Clinical criteria and appropriately selected tests provide additional context. 9 11
Menopause does not prevent a new STI. Your exposure history and symptoms help a clinician decide whether sexual-health testing fits your situation. 12
External white patches, fragile skin, sores, or lumps need examination
Lichen sclerosus is one example of an inflammatory condition that can affect genital skin. It may cause itchy, white, fragile patches, cracking, or scarring. Those features are reasons for examination, not a reliable self-diagnostic pattern. 5
Persistent vulvar sores, ulcers, lumps, bleeding, or changes in skin color or texture also deserve assessment. Such findings can have many noncancerous causes, but uncertainty is not a reason to ignore them or repeatedly cover them with presumed yeast or dryness treatments. 5 7
Because lichen sclerosus, infection, irritation, and other skin changes can look similar, an in-person examination is the reliable way to distinguish them. An external examination, and sometimes additional testing or biopsy when clinically appropriate, may be needed. 4 5
Bleeding after menopause needs separate evaluation
Ask a clinician to assess any bleeding after menopause, even a single episode, spotting, or bleeding after sex. Thin tissue or friction may be one cause, while polyps, endometrial changes, cancer, and other conditions are also possible. The amount or timing alone cannot identify the cause. 6 7
This does not mean every small, stable episode of spotting automatically requires an emergency department or proves cancer. It means a moisturizer trial should not be used as a prerequisite for evaluation. Heavy bleeding, faintness, severe pain, or rapid deterioration changes the urgency.
Urinary symptoms may overlap, but systemic signs matter
Burning with urination, urgency, or frequency can occur around menopause, but they should not automatically be attributed to GSM. A urinary infection or another urinary condition may need assessment. 1 10
Fever, shivering, pain in the side or back, or visible blood in the urine increases concern for a urinary infection that needs urgent assessment. Acute confusion, marked drowsiness, or difficulty speaking is an emergency pattern, not a dryness symptom to manage with a product comparison. 10
Moisturizers and lubricants answer narrower questions
A lubricant is generally used to reduce friction during sexual activity. A vaginal moisturizer is used to support moisture over time. Either may help some dryness-related symptoms, but neither establishes why the symptoms are occurring. 3 12
For exact formulation, route, ingredients, use pattern, and condom-material compatibility, see vaginal moisturizers for menopause. That comparison does not diagnose the cause of symptoms.
Persistent irritation, unusual discharge, pain, urinary symptoms, bleeding, or visible skin change should not be managed by moving endlessly from one product to another.
How local vaginal estrogen differs from systemic hormone therapy
Local vaginal estrogen and systemic menopausal hormone therapy are different treatment decisions. Nonhormonal moisturizers and lubricants are also separate categories. Current guidance emphasizes shared decision-making that considers evidence, adverse effects, individual goals, and preferences. 1 2 12
A clinician should individualize the hormone product, dose, route, and sequence. A history of estrogen-sensitive cancer, current endocrine therapy, unexplained bleeding, or another significant medical factor calls for an individualized review. The clinician can weigh the evidence for your situation rather than treating hormones as always safe or always prohibited.
What an assessment may involve
Depending on your symptoms, a clinician may review products and medicines, inspect the external vulvar skin, perform a pelvic examination, and choose swabs or urine tests. Not every person needs every test. 4 11
Consent remains active throughout an examination. A patient can ask what is being done, request a pause, or ask for the examination to stop. That right does not depend on whether the symptom is believed to be hormonal, infectious, or dermatologic. 11
When to seek assessment
Arrange assessment when symptoms are persistent, recurrent, worsening, affecting daily life, or accompanied by unusual discharge, urinary symptoms, pain during sex, or a possible STI exposure. Reassessment is also appropriate after an unsuccessful over-the-counter yeast treatment rather than continuing repeated empirical treatment. 3 8 11 12
Do not delay assessment for bleeding after menopause, a persistent sore, lump, ulcer, or skin change. Seek urgent assessment for urinary symptoms with fever, shivering, flank or back pain, or visible blood in the urine. Acute confusion, marked drowsiness, difficulty speaking, severe pain, faintness, heavy bleeding, or rapidly worsening illness requires emergency evaluation. 5 6 7 10
Related guides
What should you take away?
Menopause can contribute to vaginal dryness and to genital or urinary symptoms, but it does not explain every itch. Separate external vulvar skin symptoms from internal vaginal discomfort, keep infection and skin disease visible, and treat bleeding after menopause as a reason for assessment rather than as proof of simple friction.
Moisturizers, lubricants, local vaginal estrogen, and systemic hormone therapy answer different treatment questions. None should be used to bypass evaluation of persistent symptoms, urinary warning signs, focal skin changes, sores, or postmenopausal bleeding.
Sources
- PubMed: The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. Rechecked September 7, 2026; only the published abstract was used.
- MedlinePlus: Vaginal Dryness. Rechecked September 7, 2026.
- NHS: Vaginal Dryness. Rechecked September 7, 2026.
- Royal College of Obstetricians and Gynaecologists: Skin Conditions of the Vulva. Rechecked September 7, 2026; older patient information was used only within its recorded limits.
- NHS: Lichen Sclerosus. Rechecked September 7, 2026.
- NHS: Postmenopausal Bleeding. Rechecked September 7, 2026.
- CDC: Symptoms of Vaginal and Vulvar Cancers. Rechecked September 7, 2026.
- CDC: Vulvovaginal Candidiasis. Rechecked September 7, 2026.
- CDC: Bacterial Vaginosis. Rechecked September 7, 2026.
- NHS: Urinary Tract Infections. Rechecked September 7, 2026.
- NHS: Vaginitis. Rechecked September 7, 2026.
- The Menopause Society: Sexual Health. Rechecked September 7, 2026.